Stay updated on Avelumab Program Rollover Study Clinical Trial

Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab Program Rollover Study Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record, indicating restricted access. Added elements include the 403 header and a Home link, signaling a site-access issue rather than an update to the study information.
    Difference
    17%
    Check dated 2026-09-20T01:54:56.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page adds a new study ID entry '2018 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers. The page revision label is updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T23:47:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Adds IPD sharing policy details, including the plan to share individual participant data, access criteria, and time frames, along with related links and identifiers. This expansion provides information on how de-identified data may be requested and shared with qualified researchers.
    Difference
    88%
    Check dated 2026-08-15T23:19:34.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new revision label, v3.6.5, was added and the previous label v3.6.4 was removed. This updates the page's revision metadata but does not change the study content or functionality.
    Difference
    0.0%
    Check dated 2026-08-08T18:19:29.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.4, replacing v3.6.3, indicating a small update to the page's content or presentation.
    Difference
    0.0%
    Check dated 2026-07-25T09:27:57.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The study record gains two new Japan cross-reference identifiers: JapicCTI-194697 and jRCT2080224625. It also updates the record with a newer revision tag (Revision: v3.6.3) and recent dates, reflecting metadata enhancements to the entry.
    Difference
    0.2%
    Check dated 2026-07-03T23:47:56.000Z thumbnail image

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.